相关实验视频
Updated: Jul 19, 2025

Experimental Human Pneumococcal Carriage
Published on: February 15, 2013
同时使用肺炎球菌合疫苗降低了对甲型肝炎疫苗的免疫反应:一项随机对照试验
Marianna Riekkinen1, Sari H Pakkanen2, Veronik Hutse3
1Meilahti Vaccine Research Center, MeVac, University of Helsinki and Helsinki University Hospital, Helsinki, Finland; Department of Infectious Diseases, Inflammation Center, Helsinki University Hospital, Helsinki, Finland; Human Microbiome Research Unit, University of Helsinki, Helsinki, Finland; Travel Clinic, Aava Medical Center, Helsinki, Finland.
同时使用甲型肝炎疫苗 (HepA) 和肺炎球菌联合疫苗 (PCV13) 没有引起安全问题. 然而,联合疫苗显著降低了对HepA的抗体反应.
科学领域:
- 免疫学 免疫学 免疫学
- 疫苗学 疫苗学 疫苗学
- 公共卫生 公共卫生
背景情况:
- 通常使用的是甲型肝炎 (HepA) 和肺炎球菌联合疫苗 (PCV).
- 了解这些疫苗联合使用的安全性和免疫性对于优化疫苗接种策略至关重要.
研究的目的:
- 评估联合使用甲型肝炎疫苗 (HepA) 与13肺炎球菌联合疫苗 (PCV13) 的安全性和免疫性.
主要方法:
- 一项随机对照试验涉及305名成年志愿者,他们被分配接受PCV13 + HepA,单独PCV13或单独 HepA.
- 测量包括抗肺炎球菌IgG,OPA标位,以及疫苗接种前后的抗HAV抗体度.
- 在接种疫苗后4周内,对不良事件进行了监测.
主要成果:
- 虽然PCV13的联合使用没有影响PCV13的免疫性 (除了3型血清),但与单独的HepA相比,它显著降低了抗HAV抗体度和获得保护位的个体比例.
- 安全性概况相似,当HepA和PCV13联合使用时,不增加不良事件.
结论:
- 同时服用HepA和PCV13是安全的,并且不会影响PCV13的免疫反应,除了对3型血清型的潜在影响.
- 然而,同时使用会显著降低对甲型肝炎疫苗的抗体反应.
相关概念视频
Vaccinations
Hepatic Drug Clearance: Effect of Protein Binding
For low-extraction-ratio drugs that are less than 80% protein-bound, minor changes in protein binding...
Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
Hepatic Drug Excretion: Influencing Factors
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Dose-Response Relationship: Potency and Efficacy

